REDX IMMUNOLOGY LIMITED
Research and experimental development on biotechnology
REDX IMMUNOLOGY LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Full company profile for REDX IMMUNOLOGY LIMITED (09000503), an active life sciences and medical technology company based in United Kingdom. Incorporated 16 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2015–2024)
Cash in Bank
£202.55k
Net Assets
-£59.14M
Total Liabilities
£62.40M
Turnover
£186.82k
Employees
3
Debt Ratio
1917%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Anson, Lisa Mary Whewell | Director | British | England | 7 Feb 2020 | Active |
| Claire Penelope Solk | Secretary | Unknown | Unknown | 1 Sept 2022 | Active |
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Redx Pharma Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Neil David Murray
Ceased 3 Nov 2017
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 20 Apr 2026 | Confirmation Statement | Confirmation statement made on 16 Apr 2026 with updates | |
| 19 Apr 2026 | Mortgage | Mortgage Create With Deed With Charge Number Charge Creation Date | |
| 2 Oct 2025 | Officers | Appointment of Mr Andrew William Booth as director on 1 Oct 2025 | |
| 1 Oct 2025 | Officers | Termination of Claire Penelope Solk as director on 30 Sept 2025 | |
| 29 May 2025 | Officers | Appointment of Peter Collum as director on 29 May 2025 |
Confirmation statement made on 16 Apr 2026 with updates
Mortgage Create With Deed With Charge Number Charge Creation Date
Appointment of Mr Andrew William Booth as director on 1 Oct 2025
Termination of Claire Penelope Solk as director on 30 Sept 2025
Appointment of Peter Collum as director on 29 May 2025
Recent Activity
Latest Activity
Confirmation statement made on 16 Apr 2026 with updates
2 weeks ago on 20 Apr 2026
Mortgage Create With Deed With Charge Number Charge Creation Date
2 weeks ago on 19 Apr 2026
Appointment of Mr Andrew William Booth as director on 1 Oct 2025
7 months ago on 2 Oct 2025
Termination of Claire Penelope Solk as director on 30 Sept 2025
7 months ago on 1 Oct 2025
Appointment of Peter Collum as director on 29 May 2025
11 months ago on 29 May 2025